| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $491.2M | +0.2% |
| Cost of Revenue | $323.6M | -8.7% |
| Gross Profit | $167.6M | +23.2% |
| R&D Expense | $68.6M | +6.1% |
| SG&A Expense | $56.4M | +0.8% |
| Operating Income | -$24.9M | +56.2% |
| Pre-tax Income | -$20.9M | +62.5% |
| Income Tax | $1.2M | +20.5% |
| Net Income | -$22.0M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $56.5M | -32.7% |
| Accounts Receivable | $65.4M | -0.9% |
| Inventory | $38.4M | -17.5% |
| Current Assets | $250.5M | +7.6% |
| Total Assets | $285.5M | +4.9% |
| Current Liabilities | $161.5M | -0.5% |
| Total Liabilities | $182.3M | -1.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $38.3M | +183.3% |
| Capital Expenditures | $2.8M | +41.6% |
| Investing Cash Flow | -$50.7M | -59.5% |
| Financing Cash Flow | -$15.1M | -8.6% |
| Free Cash Flow | $35.5M | +173.9% |
| +61.1% |
| EPS (Basic) | -$0.24 | +63.1% |
| EPS (Diluted) | -$0.24 | +63.1% |
| Stockholders' Equity |
| $103.3M |
| +17.8% |